What Atea Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 0 |
| Total trades | 0 | 21 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,064,298 |
| Disposed | 0 | 176,108 |
| Net activity | +0 | +888,190 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Adams Jerome M. | Director | Jun 18 | Exercise / conversion · M | +29,600 | — | — | 92,350 |
| Polsky Bruce | Director | Jun 18 | Exercise / conversion · M | +29,600 | — | — | 124,806 |
| Murphy Polly A. | Director | Jun 18 | Exercise / conversion · M | +29,600 | — | — | 121,745 |
| Duncan Barbara Gayle | Director | Jun 18 | Exercise / conversion · M | +29,600 | — | — | 92,350 |
| Berger Franklin M | Director | Jun 18 | Exercise / conversion · M | +29,600 | — | — | 536,097 |
| Lucidi Bruno | Director | Jun 18 | Exercise / conversion · M | +29,600 | — | — | 142,350 |
| Murphy Polly A. | Director | May 18 | Open-market buy · P | +6,100 | $4.17 | +$25.4K | 92,145 |
| Corcoran Andrea | See Remarks | Mar 11 | Exercise / conversion · M | +60,000 | $1.24 | +$74.4K | 823,576 |
| Sommadossi Jean-Pierre | President, CEO, and Chairman | Feb 03 | Exercise / conversion · M | +300,000 | $1.24 | +$372K | 767,830 |
| Hammond Janet Mj | Chief Development Officer | Jan 31 | Withheld — tax / exercise cost · F | −14,136 | $4.24 | −$59.9K | 127,665 |
| Hammond Janet Mj | Chief Development Officer | Jan 31 | Exercise / conversion · M | +58,050 | — | — | 141,801 |
| Vavricka John | Chief Commercial Officer | Jan 31 | Withheld — tax / exercise cost · F | −11,570 | $4.24 | −$49.1K | 82,594 |
| Vavricka John | Chief Commercial Officer | Jan 31 | Exercise / conversion · M | +42,083 | — | — | 94,164 |
| Horga Maria Arantxa | Chief Medical Officer | Jan 31 | Withheld — tax / exercise cost · F | −16,073 | $4.24 | −$68.1K | 96,086 |
| Horga Maria Arantxa | Chief Medical Officer | Jan 31 | Exercise / conversion · M | +51,283 | — | — | 112,159 |
| Corcoran Andrea | See Remarks | Jan 31 | Withheld — tax / exercise cost · F | −16,104 | $4.24 | −$68.3K | 763,576 |
| Corcoran Andrea | See Remarks | Jan 31 | Exercise / conversion · M | +54,866 | — | — | 779,680 |
| Sommadossi Jean-Pierre | President, CEO, and Chairman | Jan 31 | Withheld — tax / exercise cost · F | −106,093 | $4.24 | −$450K | 467,830 |
| Sommadossi Jean-Pierre | President, CEO, and Chairman | Jan 31 | Exercise / conversion · M | +272,983 | — | — | 573,923 |
| Foster Wayne | EVP, Chief Accounting Officer | Jan 31 | Withheld — tax / exercise cost · F | −12,132 | $4.24 | −$51.4K | 79,329 |
Loading...
